NCT01568203 First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT01563185 Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE4
NCT01561963 A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast Status COMPLETED Phase PHASE1
NCT01555268 Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01554852 Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients Status UNKNOWN Phase PHASE3
NCT01549431 Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01545648 Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer Status TERMINATED Phase PHASE2
NCT01544114 A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) Status COMPLETED Phase PHASE4
NCT01543620 Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT01543204 Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab Status TERMINATED Phase PHASE4
NCT01541072 Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation Status TERMINATED Phase NA
NCT01516879 Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study Status COMPLETED Phase PHASE3
NCT01516619 Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia Status COMPLETED Phase PHASE2
NCT01510951 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis Status COMPLETED Phase PHASE1
NCT01508000 Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases Status TERMINATED Phase PHASE2
NCT01502982 Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04) Status COMPLETED Phase PHASE2
NCT01497821 AMG 172 First in Human Study in Patients With Kidney Cancer Status COMPLETED Phase PHASE1